Biomarkers in type 1 diabetes: application to the clinical trial setting.

Tooley, James E; Herold, Kevan C

Tooley, James E; Herold, Kevan C.

Affiliation

Tooley JE; Department of Immunobiology and Internal Medicine, Yale University, New Haven, Connecticut, USA.

Curr Opin Endocrinol Diabetes Obes ; 21(4): 287-92, 2014 Aug.

Article in En | MEDLINE | ID: mdl-24937037

Subject(s)

Autoantibodies/metabolism; Autoantigens/metabolism; Diabetes Mellitus, Type 1/metabolism; Disease Progression; Insulin-Secreting Cells/metabolism; Interleukin-18/metabolism; T-Lymphocytes/metabolism; Biomarkers/metabolism; Diabetes Mellitus, Type 1/physiopathology; Flow Cytometry; Humans; Immunoblotting

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autoantibodies / Autoantigens / T-Lymphocytes / Disease Progression / Interleukin-18 / Diabetes Mellitus, Type 1 / Insulin-Secreting Cells Type of study: Prognostic_studies Limits: Humans Language: En Journal: Curr Opin Endocrinol Diabetes Obes Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2014 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google